For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The global Metformin Hydrochloride market size is expected to reach $ 556 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).
China is the largest market with about 27% revenue market share.
The key players are Wanbury, USV, Exemed Pharmaceuticals, Vistin Pharma, Aarti Drugs, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Keyuan Pharmaceutical, CR Double-Crane, Shouguang Fukang Pharmaceutical etc. USV is the largest manufacturer with about 18% revenue market share. In terms of product type, Metformin HCL is the largest segment, occupied for a share of about 80%, and in terms of application, Metformin Hydrochloride Tablets has a share about 70 percent.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform.
In this report, our statistics is given by metformin hydrochloride API.
This report studies the global Metformin Hydrochloride production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Metformin Hydrochloride, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Metformin Hydrochloride that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Metformin Hydrochloride total production and demand, 2018-2029, (K MT)
Global Metformin Hydrochloride total production value, 2018-2029, (USD Million)
Global Metformin Hydrochloride production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Metformin Hydrochloride consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Metformin Hydrochloride domestic production, consumption, key domestic manufacturers and share
Global Metformin Hydrochloride production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Metformin Hydrochloride production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Metformin Hydrochloride production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT).
This reports profiles key players in the global Metformin Hydrochloride market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem and Shijiazhuang Polee Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Metformin Hydrochloride market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Metformin Hydrochloride Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Global Metformin Hydrochloride Market, Segmentation by Type
- Metformin HCL
- Metformin DC
Global Metformin Hydrochloride Market, Segmentation by Application
- Metformin Hydrochloride Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Others
Companies Profiled:
- Wanbury
- USV
- Shouguang Fukang Pharmaceutical
- Vistin Pharma
- CR Double-Crane
- Keyuan Pharmaceutical
- Farmhispania Group
- Harman Finochem
- Shijiazhuang Polee Pharmaceutical
- Aarti Drugs
- Exemed Pharmaceuticals
Key Questions Answered
1. How big is the global Metformin Hydrochloride market?
2. What is the demand of the global Metformin Hydrochloride market?
3. What is the year over year growth of the global Metformin Hydrochloride market?
4. What is the production and production value of the global Metformin Hydrochloride market?
5. Who are the key producers in the global Metformin Hydrochloride market?